Analytical Data
-
基因名
VxXXC
- Application
-
别名
VxXIIC
-
种属
Conus vexillum
-
表达系统
E. coli
-
标签
N- His-SUMO & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0C1W7
-
表达区间
1-47aa
-
分子量
25.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VxXXC is a recombinant protein that has garnered significant attention in the field of immunology and vaccine development. Its design is rooted in the necessity to enhance immune responses against various pathogens, particularly in the context of emerging infectious diseases. With the increasing global burden of viral infections and the limitations of traditional vaccine platforms, researchers have focused on engineered proteins that can elicit robust immune responses. The VxXXC protein structure incorporates elements that promote better antigen presentation and stimulate both humoral and cellular immunity. Previous studies have suggested that recombinant proteins such as VxXXC can be tailored to improve stability and efficacy, making them suitable candidates for vaccines and therapeutics. The ongoing research aims to elucidate the mechanisms by which VxXXC functions, exploring its interactions with immune cells and the resulting modulation of immune pathways. This background underscores the potential of VxXXC in the advancement of next-generation vaccines that are not only effective but also safe and adaptable to the rapidly changing landscape of global health threats.
